Risedronate for the prevention and treatment of postmenopausal osteoporosis.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 14584020)

Published in Cochrane Database Syst Rev on January 01, 2003

Authors

A Cranney1, L Waldegger, N Zytaruk, B Shea, B Weaver, A Papaioannou, V Robinson, G Wells, P Tugwell, J D Adachi, G Guyatt

Author Affiliations

1: Division of Rheumatology, Queen's University, Etherington Hall (Room 2004), Stuart street, Kingston, Ontario, CANADA, K7L 3N6.

Articles by these authors

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA (1998) 23.39

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31

A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials (1995) 9.85

A methodological framework for assessing health indices. J Chronic Dis (1985) 9.76

Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16

Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA (1994) 7.85

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Academic medicine and the pharmaceutical industry: a cautionary tale. CMAJ (1994) 6.98

Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97

Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med (1995) 6.23

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21

A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns (1998) 5.40

Problems in the handling of clinical and research evidence by medical practitioners. Arch Intern Med (1983) 5.16

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09

A critical appraisal of the efficacy of continuing medical education. JAMA (1984) 4.95

A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) (2003) 4.86

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81

Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73

Determining optimal therapy--randomized trials in individual patients. N Engl J Med (1986) 4.49

Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA (1994) 4.49

Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16

Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA (1995) 4.14

Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand (2003) 3.79

Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77

The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65

Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65

Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64

Validity and reliability of a questionnaire for measuring child oral-health-related quality of life. J Dent Res (2002) 3.59

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 3.45

Computer searching of the medical literature. An evaluation of MEDLINE searching systems. Ann Intern Med (1985) 3.45

Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45

CODIS STR loci data from 41 sample populations. J Forensic Sci (2001) 3.43

Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care (1996) 3.37

A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA (1997) 3.26

The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22

Raised ESR in polymyalgia rheumatica no longer a sine qua non? Lancet (1996) 3.20

Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making (1998) 3.18

The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13

Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98

The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis (1985) 2.96

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92

The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89

The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85

The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res (2008) 2.81

Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol (1998) 2.77

Back to the future: the pyramids of rheumatoid arthritis. J Rheumatol (1997) 2.76

Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75

Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum (2006) 2.73

Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int (2001) 2.67

Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev (2002) 2.65

Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58

Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ (1995) 2.58

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev (2005) 2.57

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51

Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol (1990) 2.50

Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50

Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48

Peripheral nerve function in sepsis and multiple organ failure. Chest (1991) 2.46

Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol (1998) 2.39

N of 1 randomized trials for investigating new drugs. Control Clin Trials (1990) 2.37

The International Clinical Epidemiology Network (INCLEN): a progress report. J Clin Epidemiol (1991) 2.32

The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32

Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM (2010) 2.27

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23

Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ (1997) 2.23

Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association. CMAJ (1995) 2.23

Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (2006) 2.21

Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19

Setting educational priorities for learning the concepts of population health. Med Educ (1989) 2.19

Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18

Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16

Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14